Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

Bristol-Myers Squibb prepares melatonergic agents

Jan. 7, 1998

SKB reports prodrugs of 5-HT2C receptor antagonists

Jan. 7, 1998

New CNS growth factor identified by Boston Life Sciences collaborators

Jan. 7, 1998

Potential new application for lamotrigine in Lennox-Gastaut syndrome?

Jan. 7, 1998

Nootropic agent evaluated for the treatment of stroke

Jan. 5, 1998

Lubeluzole improves clinical outcome in stroke patients

Jan. 5, 1998

Antiamnesic compounds described by Gedeon Richter

Jan. 5, 1998

Canadian researchers design new cysteine protease inhibitors

Jan. 2, 1998

FDA deems Provigil approvable

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...